Health Canada has granted approval for GlaxoSmithKline’s ( GSK) Ojjaara (momelotinib) for treating myelofibrosis (MF) in ...
Celesta Capital, a global deep tech venture capital firm, today announced it is welcoming 2013 Nobel Laureate Dr. James Rothman as a Senior Advisor. Dr. Rothman will apply his expertise as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback